NEW YORK (GenomeWeb News) – BG Medicine today announced a deal with Kindstar Diagnostics to offer galectin-3 testing services in China.

Kindstar, based in Wuhan, China, is the largest esoteric diagnostic testing business in the country, BGM said, and offers laboratory testing services to more than 2,000 hospitals there. BGM noted that much of China's population pays out of pocket for essential medical services, providing "a ready market for diagnostic testing services like galectin-3 testing," by allowing BGM to bypass reimbursement issues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.